Share on LinkedInShare on LinkedIn

ARTICLE · 08 NOVEMBER 2007

CMS Issues Final Phase III Stark Regulations, While Also Proposing New Stark Rules

Proskauer Rose LLP
Proskauer Rose LLP
Contributor
Proskauer Rose LLP

Proskauer Rose LLP

Firm Overview Proskauer is an elite global law firm with more than 900 lawyers across key financial...

View firm profile
Explore more from Proskauer Rose LLP

Late this summer, the Center for Medicare & Medicaid Services ("CMS") gave with one hand, while taking with the other. Bringing a seeming finality to the Stark Law landscape, CMS promulgated the third and apparently last phase of its final regulations for the federal physician self-referral prohibition, commonly known as the "Stark Law," (72 Fed. Reg. 51012; the "Phase III regulations").

United StatesFood, Drugs, Healthcare, Life Sciences

1. Introduction

Late this summer, the Center for Medicare & Medicaid Services ("CMS") gave with one hand, while taking with the other. Bringing a seeming finality to the Stark Law landscape, CMS promulgated the third and apparently last phase of its final regulations for the federal physician self-referral prohibition, commonly known as the "Stark Law," (72 Fed. Reg. 51012; the "Phase III regulations"). In general, this latest CMS effort continued to reflect a pragmatic and functional approach. But CMS also has made proposals for more dramatic changes to these regulations, which are in regulatory limbo.

The most critical portion of the Phase III regulations is a provision that closes a significant loophole that was created by the Phase II regulations, and was identified in our May 2004 Health Law Alert concerning the Phase II regulations [Titled: Health Law Alert - Stark Law Final Regulations: Phase II (http://www.proskauer.com/

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from